R, P., & Bashir, S. (2016). CRITICAL REVIEW OF PHARMACOGENOMICS IN ANTIPARKINSONIAN DRUG THERAPY: IMPACT ON CLINICAL MANAGEMENT OF PARKINSON’S DISEASE. Asian Journal of Pharmaceutical and Clinical Research, 9(6), 24–27. https://doi.org/10.22159/ajpcr.2016.v9i6.13350